Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Insmed

NASDAQ INSM
$24.93 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.70B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
4.38B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.23
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
148.46M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-19.55 %

Upcoming events Insmed

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Insmed

Stock analysis Insmed

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-4.96 28.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
-11.15 4.33
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-6.19 9.95
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-0.97 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
160.69 7.67

Price change Insmed per year

22.00$ 45.44$
Min Max

Summary analysis Insmed

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Insmed

Revenue and net income Insmed

All parameters

Stock news Insmed

All news
5 September 2023 в 17:15

Insmed Shares Hit 52-Week High After Positive Data for Arikayce

5 September 2023 в 17:15

Insmed Shares Hit 52-Week High After Positive Data for Arikayce

6 December 2021 в 14:45

Insmed started at overweight with $45 stock price target at J.P. Morgan

About company Insmed

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Address:
700 US Highway 202/206, Bridgewater, NJ, United States, 08807-1704
Company name: Insmed
Issuer ticker: INSM
ISIN: US4576693075
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2000-06-01
Sector: Healthcare
Industry: Biotechnology
Site: https://www.insmed.com

On which stock exchange are Insmed (INSM) stocks traded?

Insmed (INSM) stocks are traded on NASDAQ.

What is the ticker of Insmed stocks (INSM)?

The stock ticker of Insmed’s stocks or in other words, the code is INSM. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Insmed (INSM) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Insmed (INSM) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Insmed (INSM) stocks traded?

Insmed (INSM) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Insmed (INSM) stocks today?

The current price of Insmed stocks on 16.05.2024 is 24.93 dollars. per share.

What is the dynamics of Insmed (INSM) stocks from the beginning of the year?

Insmed (INSM) quotes have increased by -16.73% from the beginning of the year up to 24.93 dollars. per 1 stocks.

How much did Insmed (INSM) stocks increase in мае 2024?

This month Insmed (INSM) quotes have increased by -2.58% to 24.93 dollars. per share.

How much are Insmed (INSM) stocks worth?

Today, on October, 16.05.2024 Insmed’s (INSM) stocks cost 24.93 dollars..

What is the market capitalization of Insmed (INSM)?

Capitalization is the market value of Insmed (INSM) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Insmed (INSM) is estimated at about 3701008080 dollars.